{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:18:13Z","timestamp":1792466293723,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2335,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Host & Microbe"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.chom.2007.03.002","type":"journal-article","created":{"date-parts":[[2007,4,19]],"date-time":"2007-04-19T07:35:48Z","timestamp":1176968148000},"page":"135-145","source":"Crossref","is-referenced-by-count":281,"title":["The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection"],"prefix":"10.1016","volume":"1","author":[{"given":"Theodore C.","family":"Pierson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steevenson","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Oliphant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant E.","family":"Nybakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daved\u00a0H.","family":"Fremont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chom.2007.03.002_bib1","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1128\/JVI.75.9.4268-4275.2001","article-title":"Mutational evidence for an internal fusion peptide in flavivirus envelope protein E","volume":"75","author":"Allison","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib2","first-page":"367","article-title":"Observations on anti-phage sera. I. \u2018The percentage law\u2019","volume":"14","author":"Andrewes","year":"1933","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.chom.2007.03.002_bib3","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1099\/0022-1317-67-11-2539","article-title":"Antibody-mediated early death in\u00a0vivo after infection with yellow fever virus","volume":"67","author":"Barrett","year":"1986","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib4","doi-asserted-by":"crossref","first-page":"13097","DOI":"10.1128\/JVI.76.24.13097-13100.2002","article-title":"Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein","volume":"76","author":"Beasley","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1086\/376870","article-title":"Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating west nile virus infection in mice","volume":"188","author":"Ben-Nathan","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.chom.2007.03.002_bib6","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1128\/JVI.75.8.4002-4007.2001","article-title":"Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein","volume":"75","author":"Bhardwaj","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.micro.56.012302.160654","article-title":"The molecular biology of West Nile Virus: A new invader of the western hemisphere","volume":"56","author":"Brinton","year":"2002","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.chom.2007.03.002_bib8","first-page":"109","article-title":"A model for neutralization of viruses based on antibody coating of the virion surface","volume":"260","author":"Burton","year":"2001","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.chom.2007.03.002_bib9","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/infdis\/130.6.634","article-title":"Cyclophosphamide-potentiated West Nile viral encephalitis: Relative influence of cellular and humoral factors","volume":"130","author":"Camenga","year":"1974","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.chom.2007.03.002_bib10","first-page":"3","article-title":"Clinical manifestations in the West Nile virus outbreak","volume":"48","author":"Ceausu","year":"1997","journal-title":"Rom. J. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1099\/vir.0.80411-0","article-title":"Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein","volume":"86","author":"Chu","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/viro.1998.9357","article-title":"DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus","volume":"250","author":"Colombage","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.chom.2007.03.002_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cimid.2004.03.009","article-title":"West Nile: Worldwide current situation in animals and humans","volume":"27","author":"Dauphin","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.chom.2007.03.002_bib14","doi-asserted-by":"crossref","first-page":"37183","DOI":"10.1074\/jbc.M605429200","article-title":"The location of asparagine-linked glycans on West Nile virions controls their interactions with CD209 (dendritic cell-specific ICAM-3 grabbing nonintegrin)","volume":"281","author":"Davis","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chom.2007.03.002_bib15","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/JVI.80.3.1290-1301.2006","article-title":"West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection","volume":"80","author":"Davis","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3201\/eid1202.050871","article-title":"Introductions of West Nile virus strains to Mexico","volume":"12","author":"Deardorff","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.chom.2007.03.002_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/0022-1317-38-1-1","article-title":"A multi-hit model for the neutralization of animal viruses","volume":"38","author":"Della-Porta","year":"1978","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib18","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","article-title":"B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus","volume":"77","author":"Diamond","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/088282403322396082","article-title":"Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus","volume":"16","author":"Diamond","year":"2003","journal-title":"Viral Immunol."},{"key":"10.1016\/j.chom.2007.03.002_bib20","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1128\/JVI.77.24.12941-12949.2003","article-title":"Antibody prophylaxis and therapy against West Nile Virus infection in wild-type and immunodeficient mice","volume":"77","author":"Engle","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib21","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s007050050646","article-title":"Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: Design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins","volume":"144","author":"Falconar","year":"1999","journal-title":"Arch. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib22","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1099\/0022-1317-70-6-1605","article-title":"Antibody-dependent enhancement of yellow fever and Japanese encephalitis virus neurovirulence","volume":"70","author":"Gould","year":"1989","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib23","doi-asserted-by":"crossref","first-page":"14606","DOI":"10.1128\/JVI.79.23.14606-14613.2005","article-title":"Protective and therapeutic capacity of human single chain Fv-Fc fusion proteins against West Nile virus","volume":"79","author":"Gould","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.chom.2007.03.002_bib25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3201\/eid1108.050289a","article-title":"Epidemiology and transmission dynamics of West Nile virus disease","volume":"11","author":"Hayes","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.chom.2007.03.002_bib26","doi-asserted-by":"crossref","first-page":"11000","DOI":"10.1128\/JVI.01735-06","article-title":"Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes","volume":"80","author":"Kanai","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4269\/ajtmh.1987.36.427","article-title":"Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection","volume":"36","author":"Kaufman","year":"1987","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.chom.2007.03.002_bib28","doi-asserted-by":"crossref","first-page":"12400","DOI":"10.1073\/pnas.0603488103","article-title":"West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody","volume":"103","author":"Kaufmann","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2007.03.002_bib29","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1128\/JVI.70.6.3668-3677.1996","article-title":"Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1","volume":"70","author":"Klasse","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib30","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1099\/0022-1317-83-9-2091","article-title":"Occupancy and mechanism in antibody-mediated neutralization of animal viruses","volume":"83","author":"Klasse","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ijc.2910180405","article-title":"Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia","volume":"18","author":"Klein","year":"1976","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.chom.2007.03.002_bib32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1590\/S1020-49892006000200006","article-title":"West Nile virus activity in Latin America and the Caribbean","volume":"19","author":"Komar","year":"2006","journal-title":"Rev. Panam. Salud Publica"},{"key":"10.1016\/j.chom.2007.03.002_bib33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.chom.2007.03.002_bib34","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1126\/science.286.5448.2333","article-title":"Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States","volume":"286","author":"Lanciotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.chom.2007.03.002_bib35","series-title":"Flaviviridae: The Viruses and Their Replication","author":"Lindenbach","year":"2001"},{"key":"10.1016\/j.chom.2007.03.002_bib36","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.4049\/jimmunol.144.8.3183","article-title":"Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection","volume":"144","author":"Littaua","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.chom.2007.03.002_bib37","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.4049\/jimmunol.147.9.3139","article-title":"Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors","volume":"147","author":"Mady","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.chom.2007.03.002_bib38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope protein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.chom.2007.03.002_bib39","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1128\/JVI.79.2.1223-1231.2005","article-title":"Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein","volume":"79","author":"Modis","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0882-4010(87)90056-8","article-title":"Profiles of antibody-dependent enhancement of dengue virus type 2 infection","volume":"3","author":"Morens","year":"1987","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.chom.2007.03.002_bib41","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/508293","article-title":"Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters","volume":"194","author":"Morrey","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.chom.2007.03.002_bib42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.1089316","article-title":"Structure of West Nile virus","volume":"302","author":"Mukhopadhyay","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.chom.2007.03.002_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1067","article-title":"A structural perspective of the flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.chom.2007.03.002_bib44","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03956","article-title":"Structural basis of West Nile virus neutralization by a therapeutic antibody","volume":"437","author":"Nybakken","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.chom.2007.03.002_bib45","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.1128\/JVI.01125-06","article-title":"Crystal structure of the west nile virus envelope glycoprotein","volume":"80","author":"Nybakken","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib46","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2007.03.002_bib47","doi-asserted-by":"crossref","first-page":"12149","DOI":"10.1128\/JVI.01732-06","article-title":"Antibody recognition and neutralization determinants on domains I and II of West Nile virus envelope protein","volume":"80","author":"Oliphant","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib48","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1128\/JVI.72.5.3512-3519.1998","article-title":"Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity","volume":"72","author":"Parren","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib49","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMo020128","article-title":"West Nile virus encephalitis","volume":"347","author":"Petersen","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chom.2007.03.002_bib50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF01310983","article-title":"Passive immunization of mice with monoclonal antibodies raised against tick-borne encephalitis virus. Brief report","volume":"93","author":"Phillpotts","year":"1987","journal-title":"Arch. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virol.2005.10.030","article-title":"A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection","volume":"346","author":"Pierson","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.chom.2007.03.002_bib52","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0042-6822(92)90317-I","article-title":"Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis","volume":"187","author":"Pincus","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.chom.2007.03.002_bib53","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.20020781","article-title":"A role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.chom.2007.03.002_bib54","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.chom.2007.03.002_bib55","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1749-6632.2001.tb02704.x","article-title":"Antibody prophylaxis and therapy for flavivirus encephalitis infections","volume":"951","author":"Roehrig","year":"2001","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.chom.2007.03.002_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2005.02.020","article-title":"Characterization of neutralizing antibodies to West Nile virus","volume":"336","author":"Sanchez","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.chom.2007.03.002_bib57","doi-asserted-by":"crossref","first-page":"8364","DOI":"10.1128\/JVI.73.10.8364-8370.1999","article-title":"Stoichiometry of monoclonal antibody neutralization of T-cell line-adapted human immunodeficiency virus type 1","volume":"73","author":"Schonning","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib58","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jama.290.4.511","article-title":"Neurologic manifestations and outcome of West Nile virus infection","volume":"290","author":"Sejvar","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.chom.2007.03.002_bib59","doi-asserted-by":"crossref","first-page":"9557","DOI":"10.1128\/JVI.00080-06","article-title":"Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites","volume":"80","author":"Stiasny","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib60","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.4049\/jimmunol.143.8.2595","article-title":"Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region","volume":"143","author":"Tao","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.chom.2007.03.002_bib61","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3201\/eid0803.010238","article-title":"Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis","volume":"8","author":"Tesh","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.chom.2007.03.002_bib62","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0264-410X(01)00515-1","article-title":"Immune response to synthetic peptides of dengue prM protein","volume":"20","author":"Vazquez","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2007.03.002_bib63","doi-asserted-by":"crossref","first-page":"38755","DOI":"10.1074\/jbc.M402385200","article-title":"Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus","volume":"279","author":"Volk","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chom.2007.03.002_bib64","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.167.9.5273","article-title":"Immunization of mice against West Nile virus with recombinant envelope protein","volume":"167","author":"Wang","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.chom.2007.03.002_bib65","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1128\/JVI.79.6.3500-3508.2005","article-title":"Stoichiometry of antibody neutralization of human immunodeficiency virus type 1","volume":"79","author":"Yang","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2007.03.002_bib66","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.str.2004.06.019","article-title":"Conformational changes of the flavivirus E glycoprotein","volume":"12","author":"Zhang","year":"2004","journal-title":"Structure"}],"container-title":["Cell Host & Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312807000406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312807000406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T10:31:41Z","timestamp":1683801101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931312807000406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S1931312807000406"],"URL":"https:\/\/doi.org\/10.1016\/j.chom.2007.03.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1082872.535818","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1082872.541075","asserted-by":"object"}]},"ISSN":["1931-3128"],"issn-type":[{"value":"1931-3128","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}